Robin de Vries

Summary

Affiliation: University of Groningen
Country: The Netherlands

Publications

  1. pmc Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model
    Robin de Vries
    Unit of Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    PLoS ONE 5:e13392. 2010
  2. ncbi Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections
    Robin de Vries
    Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
    Pharmacoeconomics 26:75-90. 2008
  3. doi Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health
    Robin de Vries
    Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    Vaccine 27:846-52. 2009
  4. doi Cost-utility of repeated screening for Chlamydia trachomatis
    Robin de Vries
    Groningen University Institute for Drug Exploration University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands
    Value Health 11:272-4. 2008
  5. ncbi Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal
    Jarir Atthobari
    Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen UniversityInstitute for Drug Exploration, Groningen, The Netherlands
    Clin Ther 28:432-44. 2006
  6. doi Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
    Tjalke A Westra
    Department of Pharmacy, University of Groningen, The Netherlands
    Clin Ther 32:1479-95. 2010
  7. doi Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence
    Petros Pechlivanoglou
    Department of Pharmacoepidemiology and Pharmacoeconomics PE2, University of Groningen, Groningen, The Netherlands
    Pharmacoeconomics 29:737-51. 2011
  8. ncbi Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data
    Robin de Vries
    Groningen University Institute for Drug Exploration University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands
    Value Health 9:1-11. 2006
  9. ncbi Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting
    Rogier M Klok
    Groningen University Institute for Drug Exploration, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, The Netherlands
    Clin Ther 27:1647-57. 2005
  10. ncbi How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information
    Eric Schirm
    Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 13:173-9. 2004

Detail Information

Publications10

  1. pmc Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model
    Robin de Vries
    Unit of Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    PLoS ONE 5:e13392. 2010
    ..Using this framework, we estimate the cost-effectiveness of universal adolescent pertussis booster vaccination at the age of 12 years in the Netherlands...
  2. ncbi Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections
    Robin de Vries
    Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
    Pharmacoeconomics 26:75-90. 2008
    ..As the diagnosis of invasive fungal infections is difficult, effective antifungal prophylaxis is desirable. So far, fluconazole has been the most commonly used...
  3. doi Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health
    Robin de Vries
    Department of Pharmacy, University of Groningen, Groningen, The Netherlands
    Vaccine 27:846-52. 2009
    ..Furthermore, we showed the large impact of the discount rate for health on the cost-effectiveness of a HP vaccination program, illustrative for other vaccination programs...
  4. doi Cost-utility of repeated screening for Chlamydia trachomatis
    Robin de Vries
    Groningen University Institute for Drug Exploration University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands
    Value Health 11:272-4. 2008
    ..To estimate the cost-effectiveness of repeated screening for chlamydia trachomatis at various time intervals compared to one-off screening of Dutch young adults...
  5. ncbi Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal
    Jarir Atthobari
    Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen UniversityInstitute for Drug Exploration, Groningen, The Netherlands
    Clin Ther 28:432-44. 2006
    ....
  6. doi Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
    Tjalke A Westra
    Department of Pharmacy, University of Groningen, The Netherlands
    Clin Ther 32:1479-95. 2010
    ..Because pertussis is most severe in unimmunized infants and infants who have only received some of the recommended doses, new pertussis immunization strategies should be considered to protect this vulnerable population...
  7. doi Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence
    Petros Pechlivanoglou
    Department of Pharmacoepidemiology and Pharmacoeconomics PE2, University of Groningen, Groningen, The Netherlands
    Pharmacoeconomics 29:737-51. 2011
    ..Furthermore, we show that the results of cost-effectiveness analyses are highly dependent on several crucial factors that influence the baseline IFI incidence rates and, therefore, differ per patient population or region...
  8. ncbi Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data
    Robin de Vries
    Groningen University Institute for Drug Exploration University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands
    Value Health 9:1-11. 2006
    ..To estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (CT) screening program including partner treatment for Dutch young adults...
  9. ncbi Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting
    Rogier M Klok
    Groningen University Institute for Drug Exploration, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, The Netherlands
    Clin Ther 27:1647-57. 2005
    ..We performed an economic analysis of a Helicobacter pylori test-and-treat strategy versus a prompt endoscopy approach in a primary care setting...
  10. ncbi How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information
    Eric Schirm
    Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 13:173-9. 2004
    ....